Genomic testing has become a part of routine oncology care and plays critical roles in diagnosis, prognostic assessment, and treatment selection. Thus, in parallel, the variety of genomic testing ...
In recognition of Rare Disease Day, IMO Health today announced the operationalization of Mondo rare disease knowledge within everyday clinical workflows, expanding access to research-grade rare ...